share_log

Avenue Therapeutics | EFFECT: Others

Avenue Therapeutics | EFFECT: Others

Avenue Therapeutics | EFFECT：其他
美股sec公告 ·  05/13 18:04
牛牛AI助理已提取核心訊息
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC). The notice of effectiveness, which is a significant step for the company, was issued on May 10, 2024, at 4:00 PM. This form is typically used by companies to register securities for potential future offerings. The filing, under the file number 333-279125, indicates that Avenue Therapeutics has met the SEC's requirements to potentially offer securities to the public.
Avenue Therapeutics, Inc. has announced the effectiveness of a Form S-3 filing with the United States Securities and Exchange Commission (SEC). The notice of effectiveness, which is a significant step for the company, was issued on May 10, 2024, at 4:00 PM. This form is typically used by companies to register securities for potential future offerings. The filing, under the file number 333-279125, indicates that Avenue Therapeutics has met the SEC's requirements to potentially offer securities to the public.
Avenue Therapeutics, Inc.已宣佈向美國證券交易委員會（SEC）提交的S-3表格的生效。生效通知於2024年5月10日下午4點發布，這是公司邁出的重要一步。公司通常使用此表格來註冊證券，以備將來可能的發行。該文件編號爲333-279125，表明Avenue Therapeutics已滿足美國證券交易委員會可能向公衆發行證券的要求。
Avenue Therapeutics, Inc.已宣佈向美國證券交易委員會（SEC）提交的S-3表格的生效。生效通知於2024年5月10日下午4點發布，這是公司邁出的重要一步。公司通常使用此表格來註冊證券，以備將來可能的發行。該文件編號爲333-279125，表明Avenue Therapeutics已滿足美國證券交易委員會可能向公衆發行證券的要求。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。